{"product_id":"oakstone-addiction-medicine-for-non-specialists-2025-videos-slides-pdfs-1","title":"Oakstone Addiction Medicine for Non-Specialists 2025 (Videos + Slides PDFs)","description":"\u003ch3\u003eOakstone Addiction Medicine for Non-Specialists 2025 (Videos + Slides PDFs)\u003c\/h3\u003e\n\u003cp\u003e\u003cem\u003eAddiction Medicine for Non-Specialists\u003c\/em\u003e is a comprehensive video CME program geared toward clinicians who see patients with substance use disorders, whether substance use is the primary complaint or not. This collection of thorough and expertly informed lectures will help you more effectively screen, treat, refer, and follow up with these patients.\u003c\/p\u003e\n\u003cp\u003eLed by Antoine Douaihy, MD, experienced practitioners address the need to integrate, prioritize, and personalize care while avoiding harmful stigmas and racial and ethnic disparities. Featured continuing medical education topics include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe Pharmacology of Substances of Use\u003c\/li\u003e\n\u003cli\u003eGambling Disorders\u003c\/li\u003e\n\u003cli\u003eTechnology Addiction\u003c\/li\u003e\n\u003cli\u003eHelping Family Members Affected by Substance Use Disorders\u003c\/li\u003e\n\u003cli\u003eMindfulness-Based Treatment of Substance Use Disorders\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eTopics \/ Speakers\u003c\/h4\u003e\n\u003cdiv class=\"product-tab-content\"\u003e\n\u003cdiv id=\"tab-speaker\"\u003e\n\u003cp\u003eAddiction – An Overview – \u003cem\u003eAntoine Douaihy, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eNeurobiological Aspects of Substance Use Disorder – \u003cem\u003eJody Glance, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eThe Epidemiology of Substance Use Disorders – \u003cem\u003eAntoine Douaihy, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eScreening, Evaluation, and Diagnosis of Substance Use Disorders – \u003cem\u003eAntoine Douaihy, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eThe Pharmacology of Substances of Use – \u003cem\u003eSharon Connor, MD, and Cassandra Kruse, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eManagement of Intoxication, Withdrawal, and Perioperative Care in Individuals with Substance Use Disorders – \u003cem\u003eMegha Patel, PharmD, BCPS\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eAlcohol Use Disorder – \u003cem\u003eJulie Kmiec, DO\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eStimulant Use Disorder (StUD) – Treatment Overview and Future Therapies – \u003cem\u003eThersilla Oberbarnscheidt, MD, PhD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eOpioid Use Disorder – \u003cem\u003eJulie Kmiec, DO\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eBenzodiazepine Use and Misuse – \u003cem\u003eTae Woo Park, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eCannabis Use Disorder – \u003cem\u003eThersilla Oberbarnscheidt, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eTobacco Use Disorder – \u003cem\u003eAntoine Douaihy, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eChronic Pain and Substance Use Disorders – \u003cem\u003eAmanda Price, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eAcute Pain and Substance Use Disorder – \u003cem\u003eJulie Wilson Childers, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eBrief Interventions and Motivational Interviewing for Substance Use Disorders – \u003cem\u003eCassandra Boness, PhD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eHelping Patients with Substance Use Disorders and Co-occurring Psychiatric Psychiatric Disorders (CODs) – \u003cem\u003eDennis Daley, PhD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eThe Use of Harm Reduction Strategies with Substance Use Disorders – \u003cem\u003eDavid Loveland, PhD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003ePerinatal Substance Use Disorders – \u003cem\u003eJody Glance, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003ePharmacotherapy for Adolescents with Substance Use Disorders – \u003cem\u003eDuncan Clark, MD, PhD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eSubstance Use Disorders in Older Individuals – \u003cem\u003eKatie F. Jones, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eHealthcare and Racial Disparities in Addiction Treatment – \u003cem\u003eAntoine Douaihy, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eMedical Complications of Substance Use Disorders including HIV and HCV – \u003cem\u003eJordi Blanch, MD, PhD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003ePain and Opioid Complexity in Individuals with Serious Illness – \u003cem\u003eVarad Deshmukh, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eThe Rise of Gambling Disorder – Significance, Assessment, and Treatment in an Era of Exploding Access – \u003cem\u003eKavita Fischer, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eTechnology Addiction – \u003cem\u003eHector Colon-Rivera, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eHelping Family Members Affected by Substance Use Disorders – \u003cem\u003eDennis Daley, PhD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eMindfulness-based Treatment of Substance Use Disorders – \u003cem\u003eAntoine Douaihy, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eSafe and Efficacious Prescribing for Chronic Pain – \u003cem\u003eJames R. Latronica, DO, DFASAM\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDate of Original Release:\u003c\/strong\u003e April 30, 2025\u003cbr\u003e\u003cstrong\u003eDate Credits Expire:\u003c\/strong\u003e April 29, 2028\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":" Ambossle","offers":[{"title":"Default Title","offer_id":46548832583905,"sku":"","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0750\/1925\/6033\/files\/CIGRATE.webp?v=1749841379","url":"https:\/\/ambosslee.com\/products\/oakstone-addiction-medicine-for-non-specialists-2025-videos-slides-pdfs-1","provider":" Ambosslee","version":"1.0","type":"link"}